870837-41-5

Basic information

• Product Name: 5-bromo-2-(4-methyl-1H-imidazol-1-yl)benzonitrile
• Synonyms: 5-bromo-2-(4-methyl-1H-imidazol-1-yl)benzonitrile
• CAS NO: 870837-41-5
• Molecular Weight: 262.109
• Mol File: 870837-41-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 5-bromo-2-(4-methyl-1H-imidazol-1-yl)benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-2-(4-methyl-1H-imidazol-1-yl)benzonitrile(870837-41-5)
• EPA Substance Registry System: 5-bromo-2-(4-methyl-1H-imidazol-1-yl)benzonitrile(870837-41-5)

Safety Data

• Hazardous Substances Data: 870837-41-5(Hazardous Substances Data)

Upstream product

• 822-36-6 4-methyl-1H-imidazole 
• 179897-89-3 5-Bromo-2-fluoro-benzonitrile 

Downstream Products

• 1185015-76-2 5-(4,6-dimethyl-pyrimidin-2-ylamino)-2-(4-methyl-imidazol-1-yl)-benzonitrile 
• 1319064-55-5 5-(8-Methoxy-[1,2,4]triazolo[1,5-a]pyridin-2-ylamino)-2-(4-methyl-imidazol-1-yl)-benzonitrile 
• 890132-32-8 5-bromo-2-(5-dimethylaminomethyl-4-methyl-imidazol-1-yl)-benzonitrile 
• 1225444-48-3 5-(1,5-dimethyl-1H-[1,2,4]triazol-3-ylamino)-2-(4-methyl-imidazol-1-yl)-benzonitrile 

Relevant articles and documents

MODULATORS FOR AMYLOID BETA

The invention relates to compounds of formula wherein the substituents are as described in claim 1. Compounds of formula I are modulators for amyloid beta and thus, they may be useful for the treatment or prevention of a disease associated with the deposi

Substituted imidazo-[1,5-a][1,2,4]triazolo[1,5-d][1,4] benzodiazepine derivatives

The present invention is concerned with substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives of the following formula wherein the definition of substituents is described in the claims. This class of compounds shows high affinity

Cinnamide compound

The present invention relates to a compound represented by Formula (I): (wherein Ar1 represents an imidazolyl group which may be substituted with 1 to 3 substituents; Ar2 represents a pyridinyl group, a pyrimidinyl group, or a phenyl group which may be substituted with 1 to 3 substituents; X1 represents (1) —C≡C— or (2) a double bond etc. which may be substituted; R1 and R2 represent, for example, a C1-6 alkyl group or C3-8 cycloalkyl group which may be substituted) or a pharmacologically acceptable salt thereof and to the use thereof as pharmaceutical agents. The object of the present invention is to find a therapeutic or preventive agent for diseases caused by Aβ. According to the present invention, a therapeutic or preventive agents for diseases caused by Aβ can be provided.